Hochschulschrift
Targeting the epigenetic modifier HDAC6 for cancer therapy and for overcoming drug resistance
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
vi, 39 Blätter, 50 verschieden gezählte Blätter
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Literaturverzeichnis Seite 28-38
Enthält mehrere Zeitschriftenartikel, "Kumulative Dissertation"
Enthält deutsche und englische Zusammenfassung
Johannes Gutenberg-Universität Mainz, Dissertation, 2020
- Keyword
-
Arzneimittelresistenz
- Event
-
Veröffentlichung
- (where)
-
Mainz
- (when)
-
Oktober 2020
- Creator
- Contributor
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 2:05 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- Oktober 2020
Other Objects (12)
Bioreductive prodrugs for the targeting of epigenetic enzymes
Epigenetic targeting of esophageal cancer
The epigenetic modifier DOT1L regulates gene regulatory networks necessary for cardiac patterning and cardiomyocyte cell cycle withdrawal
Lineage-specific regulation of epigenetic modifier genes in human liver and brain
The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation
Targeting reader domains of the epigenetic code
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
Overcoming Observation Bias for Cancer Progression Modeling
Evaluation of the combined epigenetic targeting of LSD1 and HDAC for cell death induction in rhabdomyosarcoma cells
A mass spectrometry-based strategy for mapping modification sites for the ubiquitin-like modifier NEDD8
Nanocarrier system for overcoming multidrug resistance in cancer
Nanocarrier system for overcoming multidrug resistance in cancer
Bioreductive prodrugs for the targeting of epigenetic enzymes
Epigenetic targeting of esophageal cancer
The epigenetic modifier DOT1L regulates gene regulatory networks necessary for cardiac patterning and cardiomyocyte cell cycle withdrawal
Lineage-specific regulation of epigenetic modifier genes in human liver and brain
The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation
Targeting reader domains of the epigenetic code
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
Overcoming Observation Bias for Cancer Progression Modeling
Evaluation of the combined epigenetic targeting of LSD1 and HDAC for cell death induction in rhabdomyosarcoma cells
A mass spectrometry-based strategy for mapping modification sites for the ubiquitin-like modifier NEDD8
Nanocarrier system for overcoming multidrug resistance in cancer
Nanocarrier system for overcoming multidrug resistance in cancer
Bioreductive prodrugs for the targeting of epigenetic enzymes
Epigenetic targeting of esophageal cancer
The epigenetic modifier DOT1L regulates gene regulatory networks necessary for cardiac patterning and cardiomyocyte cell cycle withdrawal
Lineage-specific regulation of epigenetic modifier genes in human liver and brain
The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation
Targeting reader domains of the epigenetic code
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
Overcoming Observation Bias for Cancer Progression Modeling
Evaluation of the combined epigenetic targeting of LSD1 and HDAC for cell death induction in rhabdomyosarcoma cells
A mass spectrometry-based strategy for mapping modification sites for the ubiquitin-like modifier NEDD8
Nanocarrier system for overcoming multidrug resistance in cancer